Search

Filters

Use filters to refine the search results.

Now showing items 1-10 of 96

Cardiovascular pharmacogenetics

Myburgh, Renier; Hochfeld, Warren Ernst; Dodgen, Tyren Mark; Ker, James A.; Pepper, Michael Sean (Elsevier, 2012-03)
The risk of CAD in women

Ker, James A. (New Media Publishing, 2018-08)
An unresolved problem

Ker, James A. (Media 24, 2015-04)
Sudden infant death syndrome and left ventricular hypertrabeculation-hidden arrhythmogenic entity?

Ker, James A.; Du Toit-Prinsloo, Lorraine; Van Heerden, Willem Francois Petrus; Saayman, Gert (Libertas Academica, 2010)
Cardiovascular risk calculation

Ker, James A. (MedPharm Publications, 2014-05)
The MOGE(S) system explained

Ker, James A. (Media 24, 2015-08)
Chronic heart failure

Ker, James A. (MedPharm Publications, 2015)
Is there a difference between an angiotensin-converting enzyme inhibitor and an angiotensin-specific receptor blocker for the treatment of hypertension?

Ker, James A. (Medpharm Publications, 2015)
Obstructive sleep apnoea

Ker, James A. (Media 24, 2015-06)
Is it really a benign condition?

Ker, James A. (Media 24, 2015-06)

Now showing items 1-10 of 96